<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthritis Care Res (Hoboken)</journal-id><journal-id journal-id-type="iso-abbrev">Arthritis Care Res (Hoboken)</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Arthritis care &amp; research</journal-title></journal-title-group><issn pub-type="ppub">2151-464X</issn><issn pub-type="epub">2151-4658</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10275614</article-id><article-id pub-id-type="pmcid-ver">PMC10275614.319</article-id><article-id pub-id-type="pmcaid">10275614</article-id><article-id pub-id-type="pmcaiid">10275614</article-id><article-id pub-id-type="manuscript-id">NIHMS1904781</article-id><article-id pub-id-type="pmid">36331101</article-id><article-id pub-id-type="doi">10.1002/acr.25053</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1904781</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1904781</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Narrowing Mortality Gap: Temporal Trends of Cause-Specific Mortality in a National, Matched Cohort Study in U.S. Veterans with Rheumatoid Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names initials="TM">Tate M.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Y">Yangyuna</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roul</surname><given-names initials="P">Punyasha</given-names></name><degrees>MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sauer</surname><given-names initials="BC">Brian C.</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cannon</surname><given-names initials="GW">Grant W.</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kunkel</surname><given-names initials="G">Gary</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Michaud</surname><given-names initials="K">Kaleb</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baker</surname><given-names initials="JF">Joshua F.</given-names></name><degrees>MD, MSCE</degrees><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mikuls</surname><given-names initials="TR">Ted R.</given-names></name><degrees>MD, MSPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>England</surname><given-names initials="BR">Bryant R.</given-names></name><degrees>MD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1.</label>Medicine &amp; Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, NE</aff><aff id="A2"><label>2.</label>Division of Rheumatology &amp; Immunology, Department of Internal Medicine, University of Nebraska Medical Center (UNMC), Omaha, NE</aff><aff id="A3"><label>3.</label>Salt Lake City VA Medical Center, Salt Lake City, UT</aff><aff id="A4"><label>4.</label>University of Utah, Salt Lake City, UT</aff><aff id="A5"><label>5.</label>FORWARD (National Data Bank for Rheumatic Disease), Wichita, KS</aff><aff id="A6"><label>6.</label>Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA</aff><aff id="A7"><label>7.</label>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff><author-notes><corresp id="CR1">Corresponding author: Bryant R. England, MD, PhD; 986270 Nebraska Medical Center, Omaha, NE 68198-6270. Fax: 402.559.6788. Phone: 402.559.7288. <email>Bryant.england@unmc.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>1</month><year>2023</year></pub-date><volume>75</volume><issue>8</issue><issue-id pub-id-type="pmc-issue-id">438380</issue-id><fpage>1648</fpage><lpage>1658</lpage><pub-history><event event-type="nihms-submitted"><date><day>11</day><month>06</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-01 00:25:14.000"><day>01</day><month>08</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1904781.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objectives:</title><p id="P1">To examine temporal trends in all-cause and cause-specific mortality in patients with rheumatoid arthritis (RA) in the Veteran&#8217;s Health Administration (VHA).</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted a matched cohort study in the VHA from 1/1/2000-12/31/2017. Incident RA patients were matched up to 1:10 on age, sex, and VHA enrollment year to non-RA patients, then followed until death or end of study period. Cause of death was obtained from the National Death Index. Multivariable Cox regression models stratified by RA diagnosis years were used to examine trends in RA-related risk of all-cause and cause-specific mortality.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Among 29,779 incident RA patients (matched to 245,226 non-RA patients), 9,565 deaths occurred. RA patients were at increased risk of all-cause (aHR 1.23, 95% CI 1.20-1.26), cardiovascular (aHR 1.19, 1.14-1.23), cancer (aHR 1.19, 1.14-1.24), respiratory (aHR 1.46, 1.38-1.55), and infection-related mortality (aHR 1.59, 1.41-1.80). Interstitial lung disease (ILD) was the cause of death most strongly associated with RA (aHR 3.39, 2.88-3.99). Nearly 70% of excess deaths in RA were attributable to cardiopulmonary disease. All-cause mortality risk related to RA was lower among those diagnosed during 2012-2017 (aHR 1.10, 1.05-1.15) compared to 2000-2005 (aHR 1.31, 1.26-1.36), but still higher than non-RA controls (p&lt;0.001). Cause-specific mortality trends were similar.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Excess RA-related mortality was driven by cardiovascular, cancer, respiratory, and infectious causes, particularly cardiopulmonary diseases. Though our findings support that RA-related mortality risk is decreasing over time, a mortality gap remains for all-cause and cause-specific mortality in RA.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>